Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,329 | -55,028 | -33,026 | -13,445 | 7,028 |
| Depreciation Amortization | 815 | 614 | 417 | 530 | 1,690 |
| Income taxes - deferred | -15,666 | -11,322 | -6,228 | -2,534 | -7,431 |
| Accounts receivable | N/A | N/A | N/A | N/A | 8,281 |
| Accounts payable and accrued liabilities | 4,232 | -201 | 176 | -3,789 | -2,788 |
| Other Working Capital | 3,695 | 3,017 | 326 | -10,175 | -14,324 |
| Other Operating Activity | 6,943 | 8,116 | 4,769 | 6,000 | -41,190 |
| Operating Cash Flow | $-77,310 | $-54,804 | $-33,566 | $-23,413 | $-48,734 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 40,455 | 25,135 | 12,841 | 2,967 | -95,123 |
| PPE Investments | -26 | 16,474 | 16,474 | 8,224 | -98 |
| Net Acquisitions | 16,500 | N/A | N/A | N/A | 25,500 |
| Investing Cash Flow | $56,929 | $41,609 | $29,315 | $11,191 | $-69,721 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 263 | 263 | 149 | 149 | 179,683 |
| Financing Cash Flow | $263 | $263 | $149 | $149 | $179,683 |
| Exchange Rate Effect | -896 | -621 | -478 | -477 | 720 |
| Beginning Cash Position | 71,722 | 71,722 | 71,722 | 71,722 | 9,774 |
| End Cash Position | 50,708 | 58,169 | 67,142 | 59,172 | 71,722 |
| Net Cash Flow | $-21,014 | $-13,553 | $-4,580 | $-12,550 | $61,948 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,310 | -54,804 | -33,566 | -23,413 | -48,734 |
| Capital Expenditure | -26 | -26 | -26 | -26 | -98 |
| Free Cash Flow | -77,336 | -54,830 | -33,592 | -23,439 | -48,832 |